The Department of Health Care Services (DHCS) posted the following alerts and weekly wrap-ups on the Medi-Cal Rx Web Portal:
- Updates to the List of Contracted Personal Blood Pressure Monitoring Devices and Blood Pressure Cuffs, Effective July 1, 2023 and October 1, 2023 (June 1)
- Updates to the List of Contracted Enteral Nutrition Products, Effective July 1, 2023 and October 1, 2023 (June 1)
- Medical Supplies Update: Updates to Diabetic Blood Glucose Test Strips and Lancets Quantity Limits, Effective July 1, 2023 (June 1)
- Updates to Diabetic Testing Supplies, Effective July 1, 2023 (June 1)
- Updates to Medical Supplies: Basal Thermometers, Effective July 1, 2023 (June 1)
- Maximum Allowable Ingredient Cost 30-day Pharmacy Provider Notice (June 1)
- Medi-Cal Rx Monthly Bulletin for June (June 1)
- Changes to the Contract Drugs List (June 1)
- Changes to Contract Drugs List – Over-the-Counter Drugs (June 1)
- Changes to Family PACT Pharmacy Formulary (June 1)
- Updates to the Medi-Cal Rx Provider Manual (June 1)
- Pharmacy Locator Tool – Enhanced Functionality (May 26)
- Medi-Cal Rx Weekly Wrap-up for May 19-25 (May 26)
- Reinstatement Spotlight (May 26)
- Emergency Fill for Unbreakable Packages (May 24)
- 30-day Countdown – Phase III, Lift 4: Retirement of the Transition Policy for Beneficiaries 22 Years of Age and Older (May 23)
Also in California, Medi-Cal published this PHE Update for Who May Prescribe Home Health Services, DME and Medical Supplies (May 19).
Also in California, the Department of Health Care Services announced this Medi-Cal Rx Update.
On May 19, Medi-Cal Rx Reinstatement Phase III, Lift 3 was successfully launched. On May 23, a 30-day notification for Phase III, Lift 4: Retirement of the Transition Policy for Beneficiaries 22 Years of Age and Older was released, notifying stakeholders that on June 23, 2023, Phase III, Lift 4 (P3/L4) will be implemented, lifting the Transition Policy for 46 Standard Therapeutic Classes. This is the fourth in a series of lifts to retire the Transition Policy by reinstating NCPDP Reject Code 75 – Prior Authorization Required.
Also in California, as part of the Board of Pharmacy’s April 2023 Board Meeting, the Board approved a policy statement related to digital signatures.
Finally, the Board of Pharmacy posted the agenda for the Medication Error Reduction and Workforce Ad Hoc Committee Meeting scheduled for June 7.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.